Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis. by Lin Wang, Yabing Zheng, Hengwei Xu, Xinfeng Yan, Xiaotian Chang

Get full text

PADI3 induces cell cycle arrest via the Sirt2/AKT/p21 pathway and acts as a tumor suppressor gene in colon cancer by Xiaotian Chang, Zhengbin Chai, Jiaorui Zou, Hongxing Wang, Yao Wang, Yabing Zheng, Hui Wu, Chunyan Liu

Get full text

Maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in metastatic non-small cell lung cancer patients by Meiyu Fang, Shengye Wang, Yabing Zheng, Xiangmin Kong, Liyan Gong, Youhao Qiu, Yazhen Zhao, Weimin Mao

Get full text

The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancer. by Xiying Shao, Yong Guo, Xiaohong Xu, Yabing Zheng, Jiwen Wang, Zhanhong Chen, Jian Huang, Ping Huang, Jufen Cai, Xiaojia Wang

Get full text

PADI3 plays an antitumor role via the Hsp90/CKS1 pathway in colon cancer by Zhengbin Chai, Li Wang, Yabing Zheng, Na Liang, Xiwei Wang, Yingying Zheng, Zhiwei Zhang, Chuanxi Zhao, Tingting Zhu, Chunyan Liu

Get full text

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling by Zhanhong Chen, Tian Sun, Ziyan Yang, Yabing Zheng, Ruoying Yu, Xue Wu, Junrong Yan, Yang W Shao, Xiying Shao, Wenming Cao, Xiaojia Wang

Get full text

Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial by Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yiding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiaojia Wang

Get full text

Use of period analysis to timely assess 5-year relative survival for breast cancer patients from Taizhou, Eastern China by Runhua Li, Yabing Zheng, Jiajia Huang, Huijun Lei, Mingzhi Xu, Liangyou Wang, Luyao Zhang, Yongran Cheng, Xiyi Jiang, Huijuan Tang, Zheng Shi, Gang Chen, Huijuan Zhou, Zhijun Dai, Dalin Lu, Tianhui Chen, Tianhui Chen

Get full text

Everolimus‐containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study by Zhanhong Chen, Yabing Zheng, Wenming Cao, Yuzi Zhang, Zhengyi Zhao, Guoqiang Wang, Jing Zhao, Shangli Cai, Xiying Shao, Jian Huang, Weiwu Ye, Yuan Huang, Wei Li, Xiang Huang, Hao Wu, Xiaojia Wang, Yongmei Yin

Get full text

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World by Xingfei Yu, Chen Wang, Yabing Zheng, Beibei Miao, Jiejie Hu, Xiying Shao, Liming Sheng, Juan Lin, Yuqin Ding, Haojun Xuan, Yingying Ding, Lijie Gong, Weiliang Feng, Chengdong Qin, Daobao Chen, Yang Yu, Hongjian Yang

Get full text